Lumeda Inc. | Valuation, Funding Rounds & Stock Price | Caplight

Lumeda Inc.

Private
Connecticut
Healthcare & Life Sciences
https://oncoluxinc.com

Last Round: Series A
Date: Apr 8, 2021
Total Funding Raised: $5.3M
Momentum: Top 5% of companies Caplight tracks

Company Overview

Lumeda Inc. is a medical technology company that develops a photodynamic therapy (PDT) platform, DigiLum™, as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Lumeda Inc. Comparables

Compare Lumeda Inc. with similar companies based on industry and business-model similarity.

Company Similarity Market Cap
Hemerion Therapeutics 78% Unlock
Modulight Oyj 74% Unlock
Illumacell Inc. 71% Unlock
Comparable company 50% Unlock

Lumeda Inc. Funding Rounds

Historical fundraising activity

Round Date Amount Raised Valuation Investors Sources
Series A Apr 8, 2021 Unlock Unlock Unlock Unlock
Seed Jun 4, 2020 Unlock Unlock Unlock Unlock

Lumeda Inc. Investors

Notable investors and investment history

Investor Rounds
Connecticut Innovations Seed, Series A

Market Signals

Structured signals derived from secondary market and firmographic data.

Lumeda Inc. Filings

SEC and related filings with document metadata.

Typed Date Amount Offered Amount Sold Filling Pages Download
Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation

Lumeda Inc. Filings

Frequently Asked Questions

Firmographic Details